SYNTA PHARMACEUTICALS CORP.;THE INSTITUTE FOR CANCER RESEARCH D/B/A THE RESEARCH INSTITUTE OF FOX CHASE CANCER CENTER
发明人:
David Proia,Erica Golemis,Tamina Seeger-Nukpezah
申请号：
US14436401
公开号：
US20150283147A1
申请日:
2013.10.18
申请国别(地区):
US
年份:
2015
代理人:
摘要：
Provided are methods of treating polycystic kidney disease in a subject in need thereof, by administering to the subject in need thereof, an effective amount of a compound according to formula (I) or a pharmaceutically acceptable salt thereof, wherein the variables in the structural formulae are defined herein. Also provided are methods of treating polycystic kidney disease by a compound of formula (I) in combination with additional therapeutic agents.
